Pharmacokinetics of Digitalis in Some Domestic Animals

Yoshimichi MIYAZAWA; Tomohide SATO; Hideo MIYASHITA

doi:10.11276/jsvc1984.21.1

家畜におけるジギタリスの薬物動態

宮澤良道, 佐藤友英, 宮下英夫

著者情報

ジャーナルフリー

1988 年 21 巻 21 号 p. 1-19

DOI https://doi.org/10.11276/jsvc1984.21.1

詳細

発行日: 1988 年受付日: - J-STAGE公開日: 2010/03/05 受理日: - 早期公開日: - 改訂日: -
訂正情報
訂正日: 2010/03/05 訂正理由: - 訂正箇所: 引用文献情報訂正内容: Wrong : 1) DETWEILER, D. K.(1965): Cardiac glycosides in the treatment of congestive heart failure in dogs. J. Am. Anim. Hosp. Assoc., 1, 29-34
2) DEAR, M. G. (1979) : Agents acting on the cardiovascular system. II. Clinical use in small animals. In Pharmacological Basis of Small Animal Medicine. YOXALL, A. T. . and HIRD, J. F. R. editors, pp. 63-84, Blackwell Scientific Publications, Oxford.
3) DETWEILER, D. K.(1977): Cardiac drugs. In Veterinary Pharmacology and Therapeutics. 4th ed., JONES, L.M., BOOTH, N.H. and MCDONALD, L. E. editors, pp. 496-542, The Iowa State Universiy Press/AMES.
4) ADAMS, H. R.(1982) : Digitalis and other inotropic agents. In Veterinary Pharmacology and Therapeutics. 5th ed., BOOTH, N. H. and McDONALD, L. E. editors, pp. 435-457, The Iowa State University Press/AMES.
5) HAMLIN, R. L.(1978): Basis for selection of cardiac glycoside for dogs. Proc. 1 st Symp. Vet. Pharmacol. Therap., pp. 241-261.
6) MILLER, M. S. (1985) : Digitalis : Current concepts and clinical usage in small animals. Canine Prac., 12, 6-16.
7) JENKINS, W. L. and CLARK, D. R.(1977) : A review of drugs affecting the heart. J. Am. Vet. Med. Assoc., 171, 85-92.
8) KAUFMAN, G.M. and WEIRICH, W.E.(1983) : Oral cardiac glycoside therapy in the dog. Comb. Cont. Ed. 5 753-760_
12) HERRMANN, R.G., PARKER, R.J., HENDERSON, F. G. and CHEN, K. K. (1962):Intestinal absorption of cardiac steroids. Proc. Soc. Exp. Biol. Med., 109, 646-649.
13) BREZNOCK, E. M. (1973) : Application of canine plasma kinetics of digoxin and digitoxin to therapeutic digitalization in the dog. Am. J. Vet. Res., 34, 993-999.
14) KRASULA, R. W., GARDELLA, L. A., ZAROSLINSKI ,J. F. and MORRIS, R.N.(1976): Comparative bioavailability of four dosage forms of digoxin in dogs. Fed. Proc., 35, 327.
15) GHIRARDI, P., CATENAZZO, G., MANTERO, O, MEROTTI, G. C. and MARZO, A. (1977) : Bioavailability of digoxin in a new soluble pharmaceutical formulation in capsules. J. Pharm. Sci., 66, 267-269. 16) DERICK, A., CHAKRABARTI, S., BELPAIRE, F. and BOGAERT, M.(1979): Bioavailability of three brands of digoxin tablets in dogs. J. Vet. Pharmacol. Therap. 2, 27-29.
17) BUTTON, C., GROSS, D. R., JOHNSTON, J. T. and YAKATAN, G. J.(1980): Pharmacokinetics, bioavailability, and dosage regimens of digoxin in dogs. Am. J. Vet. Res., 41, 1230-1237.
18) BUTTON, C., GROSS, D.R., and ALLERT J,A, (1980): Application of individualized digoxin dosage regimens to canine therapeutic digitalization Am, J, Vet. Res., 41, 1238-1242.
19) PEDERSOLI. W. M, (1978) : Serum digoxin concentrations in healthy dogs treated without a loading dose. J. Vet. Pharmacol. Therap., 1, 279-284.
21) ERICHSEN, D. F., HARRIS, S. G. and UPSON, D. W. (1978): Plasma levels of digoxin in the cat: some clinical applications. J. Am. Anim. Hosp. Assoc., 14, 734-737.
22) LAHRTZ, H., SATTLER, R.W. and VAN ZWIETEN, P.A.(1968) : Uber den Blutspiegel and die Ausschidung radioaktiv markierter Herzglykoside nach deren intraduodenaler Applikation bei der Katze. Z. Gesamte Exp. Med., 148, 210-222.
23) BUTTON. C., GROSS, D.R., JOHNSTON, J.T. and YAKATAN G. J. (1980): Digoxin pharmacokinetics, bioavailability, efficacy, and dosage regimens in the horse. Am. J. Vet. Res., 41, 1388-1395.
24) PEDERSOLI, W. M., BELMONTE, A. A., PUROHIT, R. C. and NACHREINER, R. F.(1978): Pharmacokinetics of digoxin in the horse. J. Equine Med., Surgery, 2, 384-388.
25) PEDERSOLI,W. M., RAMS, W.R., BELMONTE A. A. and MCCULLERS, R. M.(1981): Pharmacokinetics of a single, orally administered dose of digoxin in horses. Am. J. Vet. Res., 42, 1412-1414.
26) BRUMBAUGH, G.W., THOMAS, W.P., ENOS, L. R, and KANEKO, J. J. (1983) : A pharmacokinetic study of digoxin in the horse. J. Vet. Pharmacol. Therap., 6, 163-172.
27) WESTERMARCK, H. (1959) : Digitalis] inactivation in vitro due to rumen microbes from sheep. Acta Vet. Scand., 1, 67-73.
29) BAGGOT, J. D. and DAVis, L. E. (1973): Plasma protein binding of digitoxin and digoxin in several mammalian species. Res. Vet. Sci., 15, 81-87.
30) GIBSON, T. P. and QUINTANILLA, A.(1980): Effect of quinidine on the renal handlig of digoxin. J. Lab. Clin. Med., 96, 1062-1070.
31) SCHAUMANN, W. and KOCH, K.(1974) : β-methyl-digoxin. VII. Tissue distribution, positive inotropic and central action in cats in comparison with other digitalis glycosides. Naunyn-Schmiedeberg's Arch. Pharmacol., 286, 195-210.
32) BERMAM, W. Jr. and MUSSELMAN, J.(1979): The relationship of age to the metabolism and protein binding of digoxin in sheep. J. Pharmacol. Exp. Ther., 208, 263-266.
33) FRANCFORT, P. and SCHATZMANN, H. J. (1976): Pharmacological experiments as a basis for the administration of digoxin in the horse. Res. Vet. Sci., 20, 84-89.
34) DOHERTY, J. E. and PERKINS, W. H.(1966): Tissue concentration and turnover of tritiated digoxin in dogs. Am. J. Cardiol., 17, 47-52.
35) BREZNOCK, E. M.(1975): Effects of phenobarbital on digitoxin and digoxin elimination in the dog. Am. J. Vet. Res., 36, 371-373.
36) DERICK, A., BELPAIRE, F. M., BOGAERT, M.G. and MATTHEEUWS, D. (1978): Plasma concentrations of digoxin and digitoxin during digitalization of healthy dogs and dogs with cardiac failure. Am. J. Vet. Res., 39, 811-815.
37) HARRISON, C. E. Jr., BRANDENBURG, O. R., ONGLEY, P.A., ORVIS, A.L. and OWEN, C.A.Jr. (1966): The distribution and excretion of tritiated substances in experimental animals following the administration of digoxin-3H. J. Lab. Clin. Med., 67, 764-777.
38) BARR, I., SMITH, T. W., KLEIN, M. D., HAGEMEIJER, F. and LOWN, B.(1972): Correlation of the electrophysiologic action of digoxin with serum digoxin concentration. J. Pharmacol. Exp. Ther., 180, 710-722.
39) GIERKE, K. D., PERRIER, D., MAYERSOHN M. and MARCUS, F.I.(1978): Digoxin disposition kinetics in dogs before and during azotemia. J. Pharmacol. Exp. Ther., 205, 459-464.
40) GASTAUER, R., ELTZE, M. and PABST, J. (1979) : Moglichkeit einer Geschlechtsabhängigkeit der Bioverfugbarkeit and Elimination verschiedener Digoxin-Zubereitungen beim Beagle. Arzneim. -Forsch., 29, 754-757.
41) KALMAN, S. M., GijLLNER, H. G., GIBSON, Th. A., KUHN, S., STINSON, E.B., MILLER, R. and HALPERN J., (1980) : A two-compartment model for digoxin disposition in dogs. Arzneim. -Forsch., 30, 943-945.
42) GIBSON, T. P. and NELSON, H. A. (1980): Digoxin alters quinidine and quinidine alters digoxin pharmacokinetics in dogs. J. Lab. Clin. Med., 95, 417-428.
43) BUTTON, C. and GROSS, D. R. (1980) : A pharmacokinetic basis for the administration of digoxin to puppies. J. Vet. Pharmacol. Therap., 3, 209-215.
44) WILKERSON, R. D., MOCKRIDGE, P. B. and MASSING, G.K.(1980): Effects of selected drugs on serum digoxin concentration in dogs. Am. J. Cardiol., 45, 1201-1210.
46) RAVIS, W.R., PEDERSOLI, W.M. and TURCO, J.D. (1987): Pharmacokinetics and interactions of digoxin with phenobarbital in dogs. Am. J. Vet. Res., 48, 1244-1249.
47) BLUSCHKE, V. and VIANA, A. P. (1976) : Digitoxin plasma half-life in the dog after administration of toxic doses. Arzneim.-Forsch., 26, 591-592.
48) KATZUNG, B. G. and MEYERS, F. H.(1965): Excretion of radioactive digitoxin by the dog. J. Pharmacol. Exp. Ther., 149, 257-262.
49) GREEFF, K., G., GREVEN, OSSWALD, W. and VIANA, A.P.(1969): Studies on the elimination of digitoxin and ouabain in the dog, using the tolerance test of repeated intravenous infusions. Arch. Int. Pharmacodyn., 179, 326-335.
50) AMLIE, J.P., STORSTEIN, L. and HELDAAS O. (1979) : Correlation between pharmacokinetics and inotropic and electrophysiologic responses to digitoxin in the intact dog. J. Cardiovasc. Pharmacol., 1, 529-540.
51) SHAH, G., NELSON, H. A., ATKINSON, A. J. Jr., OKITA, G.T., IVANOVICH, P. and GIBSON, T.P.(1979): Effect of hemoperfusion on the pharmacokinetics of digitoxin in dogs. J. Lab. Clin. Med., 93, 370-380.
52) PETERS, D. N., HAMLIN, L. R. and POWERS J. D. (1981): Absence of pharmacokinetic interaction between digitoxin and quinidine in the dog. J. Vet. Pharmacol. Therap., 4, 271-275.
54) MIYAZAWA, Y. (1987) : Plasma and tissue radioactivity of 3H-digitoxin in dogs with experimental acute renal failure. Jpn. J. Vet. Sci., 49, 859-866.
55) SELDEN, R. and SMITH, T. W.(1972): Ouabain pharmacokinetics in dog and man: Determination by radioimmunoassay. Circulation 45, 1176-1182.
56) GLANTZ, S., KERNOFF, A. R. and GOLDMAN R. H. (1976): Age-related changes in ouabain pharmacology: Ouabain exhibits a different volume of distribution in adult and young dogs. Cir. Res., 39, 407-414.
57) BOLTON, G. R. and POWELL, W. (1982) : Plasma kinetics of digoxin in the cat. Am. J. Vet. Res., 43, 1994-1999.
58) OKITA, G. T. (1967) : Species difference in duration of action of cardiac glycosides. Fed. Proc., 26, 1125-1130.
59) HEINZ, N. and FLASCH, H.(1978): Comparison of the pharmacokinetics of digoxin and dihydrodigoxin in cats in single-dose studies. Naunyn-Schmiedeberg's Arch. Pharmacol., 303, 181-187.
60) WEIDLER, D. J., JALLAD, N. S., MOVAHHED, H.S., SAKMAR, E. and WAGNER, J. G.(1978): Pharmacokinetics of digoxin in the cat and comparisons with man and the dog. Res. Commun. Chem. Pathol. Pharmacol., 19, 57-66.
61) LEHMANN, H. D.(1980): Zur experimentellen and veterinär-klinischen Pharmakologie der Herzglykoside. Praktische Tierarzt., 61, 579-588.
62) BAUER, I., NEUBERT, P. and SCHAUMANN, W. (1987): Pharmacodynamics, pharmacokinetics and metabolism of digitoxin and derivatives in cats. Naunyn-Schmiedeberg's Arch. Pharmcol., 335, 469-475.
63) FISCHER, C. S., SJOERDSMA, A. and JOHNSON, R. (1952) : The tissue, distribution and excretion of radioactive digitoxin; Studies on normal rats and cats, and rats with dietaryinduced myocardial lesions. Circulation, 5, 496-503.
65) FLASCH, H. and HEINZ, N.(1979): Pharmacokinetics of dihydrodigitoxin in the cat: A comparison with digitoxin. Naunyn-Schmiedeberg's Arch. Pharmacol., 310, 147-153.
66) DEEGEN, E., SCHMIDT-RIMPLER, K. and LIESKE, R. (1979): Untersuchungen zur Blutplasmakonzentration and Vertraglichkeit von p-Methyl-Digoxin beim Pferd. Dtsch. Tierarztl. Wschr., 86, 88-94.
67) KORITZ, G. D., ANDERSON, K. L., NEEFDAVIS, C. A. WIKCKE, J. R. and DAVIS, L. E. (1983): Pharmacokinetics of digoxin in cattle. J. Vet. Pharmacol. Therap., 6, 141-148.
68) BENTHE, H.F., DIRKSEN, G. and WEISSMÜLLER, A.(1983) : Untersuchungen ber die Digitoxinkonzentration im Blutplasma des Rindes bei unterschiedlicher Dosierung. Berl. Münch. Tiertirztl. Wschr., 96, 397-401.
69) SINGH, S,. FEHR, P. E. and MIRKIN, B. L. (1978).; Elimination kinetics and placental transfer of digoxin in pregnant and ncnpregnant ewes. Res. Commun. Chem. Pathol. Pharmacol., 20, 31-42.
70) BERMAN, W. Jr., MUSSELMAN, J. and SHORTENCARRIER, R. (1982) : The pharmacokinetics of digoxin in newborn and adult sheep. J. Pharmacokinet. Biopharm., 10, 173-186.
71) Dix, L.P., BAI, S.A., ROGERS, R. A., ANDERSON, D. L. and RIVIERE, J. E. (1985): Pharmacokinetics of digoxin in sheep: Limitations of the use of biological half-life for interspecies extrapolation. Am. J. Vet. Res., 46, 470-472.
72) MARCUS, F. I., PAVLOVICH, J., BURKHALTER, L. and CUCCIA, C.(1967): The metabolic fate of tritiated digoxin in the dog: A comparison of digitalis administration with and without a “loading dose”. J. Pharmacol. Exp. Ther., 156, 548-556.
73) MARCUS, F. I., PETERSON, A., SALEL, A., SCULLY, J. and KAPADIA, G. G.(1966) : The metabolism of tritiated digoxin in renal insufficiency in dogs and man. J. Pharmacol. Exp.Ther., 152, 372-382.
74) KUHLMANN, J., RIETBROCK, N. and SCHNIEDERS, B.(1978): Tissue distribution of cardiac glycosides. In Cardiac Glycosides, BODEM, B. 2nd DENGLER, H. J. editors pp. 109-125, Springer-Verlag, Berlin Heidelberg.
75) KUHLMANN, J., RIETBROCK, N. and SCHNIEDERS, B. (1979) : Tissue distribution and elimination of digoxin and methyldigoxin after single and multiple doses in dogs. J. Cardiovasc. Pharmacol., 1, 219-234.
76) FOURON, J. -C.(1973): Dynamic of the placental transfer of digoxin_ in the dog. Biol. Neonate., 23, 116-122,
77) HERNANDEZ, A., STRAUSS, A.W. BURTON, R.M. and GOLDRING, D. (1975): The effect of long-term administration of 3H-digoxin to the pregnant ewe upon the cardiovascular hemodynamics of the fetal lamb. Am. J. Obstet. Gynecol., 121, 1100-1102.
78) HERNANDEZ, A., BURTON, R.M., GOLDRING, D. and KLINT, R.(1973): The effect of maternally administered digoxin upon the cardiovascular hemodynamics of the fetal lamb. Am. Heart J., 85, 511-517.
79) RASMUSSEN, F., NAWAZ, M. and STEINESS, E.(1975): Mammary excretion of digoxin in goats. Acta. Pharmacol. Toxicol. 36, 377-381.
80) ABEL, R. M., LUCHI, R. J., PESKIN, G. W., CONN, H. L. Jr. and MILLER, L. D., (1965) : Metabolism of digoxin: Role of the liver in tritiated digoxin degradation. J. Pharmacol. Exp. Ther., 150, 463-468.
82) HERRMANN, 1. and REPKE, K. (1964): Speciesunterschiede in der Biotrans-formation von Digitoxin. Naunyn-Schmiedebrg's Arch. Exp. Path. Pharmak., 247, 35-48.
83) KATZUNG, B. G. and MEYERS, F. H.(1966): Biotransformation of digitoxin in the dog. J. Pharmacol. Exp. Ther., 154, 575-580.
84) RUSSELL, J. Q. and KLAASSEN, C. D.(1973): Biliary excretion of cardiac glycosides. J. Pharmacol. Exp. Ther., 186, 455-462.
85) GEILING, E. M. K. (1950) : Biosynthesis of radioactive medicinally important drugs with special reference to digitoxin. Trans. Assoc. Amer. Physicians, 63, 191-195.
86) St. GEORGE, S., BINE, R. Jr., FRIEDMAN, M., and BLAND, C. (1951) : Renal excretion of digitoxin in the rabbit and dog. Proc. Soc. Exp. Med., 78, 504-505.
87) ST. GEORGE, S,. BINE, R. Jr. and FRIEDMAN, M.(1952): Role of the liver in excretion and destruction of digitoxin. Circualtion, 6, 661-665.
89) OLIVER, G. C., SANTINI, L. A., GRIFFIN, G. and RUFFY, R.(1978): Enterohepatic circulation of digitoxin metabolites in the dog. In Cardiac Glycosides, BODEM, G. and DENGLER, H. J. editors, pp. 85-92. Springer-Verlag, Berlin Heidelberg New York.
90) LEAHEY, E. B. Jr., CARSON,, J. A. BIGGER, J. T. Jr. and BUTLER, V. P. Jr.(1979): Reduced renal clearance of digoxin during chronic quinidine administration. Circulation, 60, supp. II -16.
91) DOHERTY, J. E., STRAUB, K. D., MURPHY, M.L., DESOYZA, N. BISSETT, J.K. and KANE, J. J. (1980): Digoxin-quinidine interaction; change in canine tissue concentration from steady-state with quinidine. Am. J. Cardiol., 45. 1196-1200.
92) DERICK, A. and BELPAIRE, F.(1981): Digoxin-quinidine interaction in the dog. J. Vet. Pharmacol. Therap., 4, 215-218.
93) ROUGEOT, C., JOZEFCZAK, C., MESTRE, M., LEFUR, G. and UZAN, A.(1984): PK 10139 and quinidine: interactions with digoxin concentrations in rats and dogs. J. Pharm. Pharmacol., 36, 347-949.
94) WILKERSON, R. D. and BECK B. L. (1987): Increase in serum digoxin concentration produced by quinidine dose not increase the potential for digoxin induced ventricular arrhythmias in dogs. J. Pharmacol. Exp. Ther., 240, 548-553.
95) WARNER, N. J., LEAHE Y,E.B.Jr., HOUGEN, T. J., BIGGER, J. T. Jr, and SMITH, T. W. (1983): Tissue digoxin concentrations during the quinidine-digoxin interaction. Am. J. Cardiol., 51, 1717-1721.
96) PEDERSOLI, W.M., RAVIS, W.R. and NACHREINER, R.F. (1983): Serum digoxin concentrations in healthy dogs before, during, and after concomitant treatment with furosemide, hydrochlorthiazide, and phenytoin. J. Am. Anim. Hosp. Assoc., 19, 1031-1036.
97) PEDERSOLI, W. M., GANJAM, V. K. and NACHREINER R. F. (1980) : Serum digoxin concentrations in dogs before, during, and after concomitant treatment with phenobarbital. Am. J. Vet. Res., 41, 1639-1642.
98) PLUNKETT, L. M., GOKHALE, R. D., VALLNER, J. J. and TACKETT, R. L. (1985): Prazosin alters free and total plasma digoxin levels in dogs. Am. Heart J., 109, 847-851.
100) STEINESS, E.(1978): Digoxin toxicity compared with myocardial digoxin and potassium concentration. Br. J. Pharmacol., 63, 233-237.
101) PEDERSOLI, W. M. and NACHREINER, R. F. (1980): Serum digoxin concentrations in dogs before and during concomitant administration of furosemide. J. Vet. Pharmacol. Therap., 3, 1-7.
102) GIBSON, T. P. and QUINTANILLA, A. P. (1980): Effect of volume expansion and furosemide diuresis on the renal clearance of digoxin. J. Pharmacol. Exp. Ther., 219, 54-59.
103) WILKERSON, R. D.(1981): Acute effects of intravenous furosemide administration on serum digoxin concentration. Am. Heart J., 102, 63-65.
104) MUSGRAVE, G. E., BORN, C. K., DAVIDSON, C. P. and HAMRICK, M. E.(1977): Interaction of spircnolactcne and digoxin in dogs. J. Pharmacol. Exp. Ther., 202, 696-701.
105) Loo, J. C. K., ROWE, M. and MCGIVERAY, I. J. (1975): Effect of antacid on absorption of digoxin in dogs. J. Pharm. Sci., 64, 1727-1728.
106) ZAJTCHUK, R., CORBY, D. G., MILLER, J. G. and O'BARR, T .'P. (1975): Treatment of digoxin toxicity with activated charcoal. Am. J. Cardiol., 35, 178.
107) SCHULZ, P. and BLASCHKE, T. F. (1984): Pharmacokinetic interaction of single doses of quinine and digoxin in dogs. Pharmacology, 28, 343-346.
108) PEDERSOLI, W. M.(1980) : Serum digoxin concentrations in dogs before and after concomitant treatment with chloramphenicol. J. Am. Anim. Hosp. Assoc, 16, 839-844.
109) VARGO, T., LEWIS, R., PURDINE, J. and SCHWARTZ, A. (1975): Comparison between puppies and adult dogs following infution of digoxin. Pediatr. Res., 8, 355.
110) SINGH, S., GADGIL, S. and MIRKIN, B. L. (1978): Age dependent factors influencing digoxin pharmacokinetics in the postnatal puppy. Res. Commun. Chem. Pathol. Pharmacol., 21, 87-101.
112) DOHERTY, J. E. and YERKINS, W. H.(1966): Digoxin metabolism in hypo-and hyper-thyroidism: Studies with tritiated digoxin in thyroid disease. Ann. Inter. Med., 64, 489-507.
113) HARRON, D. W. G., SWANTON, J. G. COLLIER, P. S. and CULLEN, A. B.(1978): Digoxin plasma and myocardial level correlaticn in hypoxic dogs. J. Pharm. Pharmacol., 30(suppl.): 58 p.

Right : 1) DETWEILER, D. K.(1965): Cardiac glycosides in the treatment of congestive heart failure in dogs. J. Am. Anim. Hosp. Assoc., 1, 29-34
2) DEAR, M. G. (1979) : Agents acting on the cardiovascular system. II. Clinical use in small animals. In Pharmacological Basis of Small Animal Medicine. YOXALL, A. T. . and HIRD, J. F. R. editors, pp. 63-84, Blackwell Scientific Publications, Oxford.
3) DETWEILER, D. K.(1977): Cardiac drugs. In Veterinary Pharmacology and Therapeutics. 4th ed., JONES, L.M., BOOTH, N.H. and MCDONALD, L. E. editors, pp. 496-542, The Iowa State Universiy Press/AMES.
4) ADAMS, H. R.(1982) : Digitalis and other inotropic agents. In Veterinary Pharmacology and Therapeutics. 5th ed., BOOTH, N. H. and McDONALD, L. E. editors, pp. 435-457, The Iowa State University Press/AMES.
5) HAMLIN, R. L.(1978): Basis for selection of cardiac glycoside for dogs. Proc. 1 st Symp. Vet. Pharmacol. Therap., pp. 241-261.
6) MILLER, M. S. (1985) : Digitalis : Current concepts and clinical usage in small animals. Canine Prac., 12, 6-16.
7) JENKINS, W. L. and CLARK, D. R.(1977) : A review of drugs affecting the heart. J. Am. Vet. Med. Assoc., 171, 85-92.
8) KAUFMAN, G.M. and WEIRICH, W.E.(1983) : Oral cardiac glycoside therapy in the dog. Comb. Cont. Ed. 5 753-760_
12) HERRMANN, R.G., PARKER, R.J., HENDERSON, F. G. and CHEN, K. K. (1962):Intestinal absorption of cardiac steroids. Proc. Soc. Exp. Biol. Med., 109, 646-649.
13) BREZNOCK, E. M. (1973) : Application of canine plasma kinetics of digoxin and digitoxin to therapeutic digitalization in the dog. Am. J. Vet. Res., 34, 993-999.
14) KRASULA, R. W., GARDELLA, L. A., ZAROSLINSKI ,J. F. and MORRIS, R.N.(1976): Comparative bioavailability of four dosage forms of digoxin in dogs. Fed. Proc., 35, 327.
15) GHIRARDI, P., CATENAZZO, G., MANTERO, O, MEROTTI, G. C. and MARZO, A. (1977) : Bioavailability of digoxin in a new soluble pharmaceutical formulation in capsules. J. Pharm. Sci., 66, 267-269.
16) DERICK, A., CHAKRABARTI, S., BELPAIRE, F. and BOGAERT, M.(1979): Bioavailability of three brands of digoxin tablets in dogs. J. Vet. Pharmacol. Therap. 2, 27-29.
17) BUTTON, C., GROSS, D. R., JOHNSTON, J. T. and YAKATAN, G. J.(1980): Pharmacokinetics, bioavailability, and dosage regimens of digoxin in dogs. Am. J. Vet. Res., 41, 1230-1237.
18) BUTTON, C., GROSS, D.R., and ALLERT J,A, (1980): Application of individualized digoxin dosage regimens to canine therapeutic digitalization Am, J, Vet. Res., 41, 1238-1242.
19) PEDERSOLI. W. M, (1978) : Serum digoxin concentrations in healthy dogs treated without a loading dose. J. Vet. Pharmacol. Therap., 1, 279-284.
21) ERICHSEN, D. F., HARRIS, S. G. and UPSON, D. W. (1978): Plasma levels of digoxin in the cat: some clinical applications. J. Am. Anim. Hosp. Assoc., 14, 734-737.
22) LAHRTZ, H., SATTLER, R.W. and VAN ZWIETEN, P.A.(1968) : Uber den Blutspiegel and die Ausschidung radioaktiv markierter Herzglykoside nach deren intraduodenaler Applikation bei der Katze. Z. Gesamte Exp. Med., 148, 210-222.
23) BUTTON. C., GROSS, D.R., JOHNSTON, J.T. and YAKATAN G. J. (1980): Digoxin pharmacokinetics, bioavailability, efficacy, and dosage regimens in the horse. Am. J. Vet. Res., 41, 1388-1395.
24) PEDERSOLI, W. M., BELMONTE, A. A., PUROHIT, R. C. and NACHREINER, R. F.(1978): Pharmacokinetics of digoxin in the horse. J. Equine Med., Surgery, 2, 384-388.
25) PEDERSOLI,W. M., RAMS, W.R., BELMONTE A. A. and MCCULLERS, R. M.(1981): Pharmacokinetics of a single, orally administered dose of digoxin in horses. Am. J. Vet. Res., 42, 1412-1414.
26) BRUMBAUGH, G.W., THOMAS, W.P., ENOS, L. R, and KANEKO, J. J. (1983) : A pharmacokinetic study of digoxin in the horse. J. Vet. Pharmacol. Therap., 6, 163-172.
27) WESTERMARCK, H. (1959) : Digitalis] inactivation in vitro due to rumen microbes from sheep. Acta Vet. Scand., 1, 67-73.
29) BAGGOT, J. D. and DAVis, L. E. (1973): Plasma protein binding of digitoxin and digoxin in several mammalian species. Res. Vet. Sci., 15, 81-87.
30) GIBSON, T. P. and QUINTANILLA, A.(1980): Effect of quinidine on the renal handlig of digoxin. J. Lab. Clin. Med., 96, 1062-1070.
31) SCHAUMANN, W. and KOCH, K.(1974) : β-methyl-digoxin. VII. Tissue distribution, positive inotropic and central action in cats in comparison with other digitalis glycosides. Naunyn-Schmiedeberg's Arch. Pharmacol., 286, 195-210.
32) BERMAM, W. Jr. and MUSSELMAN, J.(1979): The relationship of age to the metabolism and protein binding of digoxin in sheep. J. Pharmacol. Exp. Ther., 208, 263-266.
33) FRANCFORT, P. and SCHATZMANN, H. J. (1976): Pharmacological experiments as a basis for the administration of digoxin in the horse. Res. Vet. Sci., 20, 84-89.
34) DOHERTY, J. E. and PERKINS, W. H.(1966): Tissue concentration and turnover of tritiated digoxin in dogs. Am. J. Cardiol., 17, 47-52.
35) BREZNOCK, E. M.(1975): Effects of phenobarbital on digitoxin and digoxin elimination in the dog. Am. J. Vet. Res., 36, 371-373.
36) DERICK, A., BELPAIRE, F. M., BOGAERT, M.G. and MATTHEEUWS, D. (1978): Plasma concentrations of digoxin and digitoxin during digitalization of healthy dogs and dogs with cardiac failure. Am. J. Vet. Res., 39, 811-815.
37) HARRISON, C. E. Jr., BRANDENBURG, O. R., ONGLEY, P.A., ORVIS, A.L. and OWEN, C.A.Jr. (1966): The distribution and excretion of tritiated substances in experimental animals following the administration of digoxin-3H. J. Lab. Clin. Med., 67, 764-777.
38) BARR, I., SMITH, T. W., KLEIN, M. D., HAGEMEIJER, F. and LOWN, B.(1972): Correlation of the electrophysiologic action of digoxin with serum digoxin concentration. J. Pharmacol. Exp. Ther., 180, 710-722.
39) GIERKE, K. D., PERRIER, D., MAYERSOHN M. and MARCUS, F.I.(1978): Digoxin disposition kinetics in dogs before and during azotemia. J. Pharmacol. Exp. Ther., 205, 459-464.
40) GASTAUER, R., ELTZE, M. and PABST, J. (1979) : Moglichkeit einer Geschlechtsabhängigkeit der Bioverfugbarkeit and Elimination verschiedener Digoxin-Zubereitungen beim Beagle. Arzneim. -Forsch., 29, 754-757.
41) KALMAN, S. M., GijLLNER, H. G., GIBSON, Th. A., KUHN, S., STINSON, E.B., MILLER, R. and HALPERN J., (1980) : A two-compartment model for digoxin disposition in dogs. Arzneim. -Forsch., 30, 943-945.
42) GIBSON, T. P. and NELSON, H. A. (1980): Digoxin alters quinidine and quinidine alters digoxin pharmacokinetics in dogs. J. Lab. Clin. Med., 95, 417-428.
43) BUTTON, C. and GROSS, D. R. (1980) : A pharmacokinetic basis for the administration of digoxin to puppies. J. Vet. Pharmacol. Therap., 3, 209-215.
44) WILKERSON, R. D., MOCKRIDGE, P. B. and MASSING, G.K.(1980): Effects of selected drugs on serum digoxin concentration in dogs. Am. J. Cardiol., 45, 1201-1210.
46) RAVIS, W.R., PEDERSOLI, W.M. and TURCO, J.D. (1987): Pharmacokinetics and interactions of digoxin with phenobarbital in dogs. Am. J. Vet. Res., 48, 1244-1249.
47) BLUSCHKE, V. and VIANA, A. P. (1976) : Digitoxin plasma half-life in the dog after administration of toxic doses. Arzneim.-Forsch., 26, 591-592.
48) KATZUNG, B. G. and MEYERS, F. H.(1965): Excretion of radioactive digitoxin by the dog. J. Pharmacol. Exp. Ther., 149, 257-262.
49) GREEFF, K., G., GREVEN, OSSWALD, W. and VIANA, A.P.(1969): Studies on the elimination of digitoxin and ouabain in the dog, using the tolerance test of repeated intravenous infusions. Arch. Int. Pharmacodyn., 179, 326-335.
50) AMLIE, J.P., STORSTEIN, L. and HELDAAS O. (1979) : Correlation between pharmacokinetics and inotropic and electrophysiologic responses to digitoxin in the intact dog. J. Cardiovasc. Pharmacol., 1, 529-540.
51) SHAH, G., NELSON, H. A., ATKINSON, A. J. Jr., OKITA, G.T., IVANOVICH, P. and GIBSON, T.P.(1979): Effect of hemoperfusion on the pharmacokinetics of digitoxin in dogs. J. Lab. Clin. Med., 93, 370-380.
52) PETERS, D. N., HAMLIN, L. R. and POWERS J. D. (1981): Absence of pharmacokinetic interaction between digitoxin and quinidine in the dog. J. Vet. Pharmacol. Therap., 4, 271-275.
54) MIYAZAWA, Y. (1987) : Plasma and tissue radioactivity of 3H-digitoxin in dogs with experimental acute renal failure. Jpn. J. Vet. Sci., 49, 859-866.
55) SELDEN, R. and SMITH, T. W.(1972): Ouabain pharmacokinetics in dog and man: Determination by radioimmunoassay. Circulation 45, 1176-1182.
56) GLANTZ, S., KERNOFF, A. R. and GOLDMAN R. H. (1976): Age-related changes in ouabain pharmacology: Ouabain exhibits a different volume of distribution in adult and young dogs. Cir. Res., 39, 407-414.
57) BOLTON, G. R. and POWELL, W. (1982) : Plasma kinetics of digoxin in the cat. Am. J. Vet. Res., 43, 1994-1999.
58) OKITA, G. T. (1967) : Species difference in duration of action of cardiac glycosides. Fed. Proc., 26, 1125-1130.
59) HEINZ, N. and FLASCH, H.(1978): Comparison of the pharmacokinetics of digoxin and dihydrodigoxin in cats in single-dose studies. Naunyn-Schmiedeberg's Arch. Pharmacol., 303, 181-187.
60) WEIDLER, D. J., JALLAD, N. S., MOVAHHED, H.S., SAKMAR, E. and WAGNER, J. G.(1978): Pharmacokinetics of digoxin in the cat and comparisons with man and the dog. Res. Commun. Chem. Pathol. Pharmacol., 19, 57-66.
61) LEHMANN, H. D.(1980): Zur experimentellen and veterinär-klinischen Pharmakologie der Herzglykoside. Praktische Tierarzt., 61, 579-588.
62) BAUER, I., NEUBERT, P. and SCHAUMANN, W. (1987): Pharmacodynamics, pharmacokinetics and metabolism of digitoxin and derivatives in cats. Naunyn-Schmiedeberg's Arch. Pharmcol., 335, 469-475.
63) FISCHER, C. S., SJOERDSMA, A. and JOHNSON, R. (1952) : The tissue, distribution and excretion of radioactive digitoxin; Studies on normal rats and cats, and rats with dietaryinduced myocardial lesions. Circulation, 5, 496-503.
65) FLASCH, H. and HEINZ, N.(1979): Pharmacokinetics of dihydrodigitoxin in the cat: A comparison with digitoxin. Naunyn-Schmiedeberg's Arch. Pharmacol., 310, 147-153.
66) DEEGEN, E., SCHMIDT-RIMPLER, K. and LIESKE, R. (1979): Untersuchungen zur Blutplasmakonzentration and Vertraglichkeit von p-Methyl-Digoxin beim Pferd. Dtsch. Tierarztl. Wschr., 86, 88-94.
67) KORITZ, G. D., ANDERSON, K. L., NEEFDAVIS, C. A. WIKCKE, J. R. and DAVIS, L. E. (1983): Pharmacokinetics of digoxin in cattle. J. Vet. Pharmacol. Therap., 6, 141-148.
68) BENTHE, H.F., DIRKSEN, G. and WEISSMÜLLER, A.(1983) : Untersuchungen ber die Digitoxinkonzentration im Blutplasma des Rindes bei unterschiedlicher Dosierung. Berl. Münch. Tiertirztl. Wschr., 96, 397-401.
69) SINGH, S,. FEHR, P. E. and MIRKIN, B. L. (1978).; Elimination kinetics and placental transfer of digoxin in pregnant and ncnpregnant ewes. Res. Commun. Chem. Pathol. Pharmacol., 20, 31-42.
70) BERMAN, W. Jr., MUSSELMAN, J. and SHORTENCARRIER, R. (1982) : The pharmacokinetics of digoxin in newborn and adult sheep. J. Pharmacokinet. Biopharm., 10, 173-186.
71) Dix, L.P., BAI, S.A., ROGERS, R. A., ANDERSON, D. L. and RIVIERE, J. E. (1985): Pharmacokinetics of digoxin in sheep: Limitations of the use of biological half-life for interspecies extrapolation. Am. J. Vet. Res., 46, 470-472.
72) MARCUS, F. I., PAVLOVICH, J., BURKHALTER, L. and CUCCIA, C.(1967): The metabolic fate of tritiated digoxin in the dog: A comparison of digitalis administration with and without a “loading dose”. J. Pharmacol. Exp. Ther., 156, 548-556.
73) MARCUS, F. I., PETERSON, A., SALEL, A., SCULLY, J. and KAPADIA, G. G.(1966) : The metabolism of tritiated digoxin in renal insufficiency in dogs and man. J. Pharmacol. Exp.Ther., 152, 372-382.
74) KUHLMANN, J., RIETBROCK, N. and SCHNIEDERS, B.(1978): Tissue distribution of cardiac glycosides. In Cardiac Glycosides, BODEM, B. 2nd DENGLER, H. J. editors pp. 109-125, Springer-Verlag, Berlin Heidelberg.
75) KUHLMANN, J., RIETBROCK, N. and SCHNIEDERS, B. (1979) : Tissue distribution and elimination of digoxin and methyldigoxin after single and multiple doses in dogs. J. Cardiovasc. Pharmacol., 1, 219-234.
76) FOURON, J. -C.(1973): Dynamic of the placental transfer of digoxin_ in the dog. Biol. Neonate., 23, 116-122,
77) HERNANDEZ, A., STRAUSS, A.W. BURTON, R.M. and GOLDRING, D. (1975): The effect of long-term administration of ³H-digoxin to the pregnant ewe upon the cardiovascular hemodynamics of the fetal lamb. Am. J. Obstet. Gynecol., 121, 1100-1102.
78) HERNANDEZ, A., BURTON, R.M., GOLDRING, D. and KLINT, R.(1973): The effect of maternally administered digoxin upon the cardiovascular hemodynamics of the fetal lamb. Am. Heart J., 85, 511-517.
79) RASMUSSEN, F., NAWAZ, M. and STEINESS, E.(1975): Mammary excretion of digoxin in goats. Acta. Pharmacol. Toxicol. 36, 377-381.
80) ABEL, R. M., LUCHI, R. J., PESKIN, G. W., CONN, H. L. Jr. and MILLER, L. D., (1965) : Metabolism of digoxin: Role of the liver in tritiated digoxin degradation. J. Pharmacol. Exp. Ther., 150, 463-468.
82) HERRMANN, 1. and REPKE, K. (1964): Speciesunterschiede in der Biotrans-formation von Digitoxin. Naunyn-Schmiedebrg's Arch. Exp. Path. Pharmak., 247, 35-48.
83) KATZUNG, B. G. and MEYERS, F. H.(1966): Biotransformation of digitoxin in the dog. J. Pharmacol. Exp. Ther., 154, 575-580.
84) RUSSELL, J. Q. and KLAASSEN, C. D.(1973): Biliary excretion of cardiac glycosides. J. Pharmacol. Exp. Ther., 186, 455-462.
85) GEILING, E. M. K. (1950) : Biosynthesis of radioactive medicinally important drugs with special reference to digitoxin. Trans. Assoc. Amer. Physicians, 63, 191-195.
86) St. GEORGE, S., BINE, R. Jr., FRIEDMAN, M., and BLAND, C. (1951) : Renal excretion of digitoxin in the rabbit and dog. Proc. Soc. Exp. Med., 78, 504-505.
87) ST. GEORGE, S,. BINE, R. Jr. and FRIEDMAN, M.(1952): Role of the liver in excretion and destruction of digitoxin. Circualtion, 6, 661-665.
89) OLIVER, G. C., SANTINI, L. A., GRIFFIN, G. and RUFFY, R.(1978): Enterohepatic circulation of digitoxin metabolites in the dog. In Cardiac Glycosides, BODEM, G. and DENGLER, H. J. editors, pp. 85-92. Springer-Verlag, Berlin Heidelberg New York.
90) LEAHEY, E. B. Jr., CARSON,, J. A. BIGGER, J. T. Jr. and BUTLER, V. P. Jr.(1979): Reduced renal clearance of digoxin during chronic quinidine administration. Circulation, 60, supp. II -16.
91) DOHERTY, J. E., STRAUB, K. D., MURPHY, M.L., DESOYZA, N. BISSETT, J.K. and KANE, J. J. (1980): Digoxin-quinidine interaction; change in canine tissue concentration from steady-state with quinidine. Am. J. Cardiol., 45. 1196-1200.
92) DERICK, A. and BELPAIRE, F.(1981): Digoxin-quinidine interaction in the dog. J. Vet. Pharmacol. Therap., 4, 215-218.
93) ROUGEOT, C., JOZEFCZAK, C., MESTRE, M., LEFUR, G. and UZAN, A.(1984): PK 10139 and quinidine: interactions with digoxin concentrations in rats and dogs. J. Pharm. Pharmacol., 36, 347-949.
94) WILKERSON, R. D. and BECK B. L. (1987): Increase in serum digoxin concentration produced by quinidine dose not increase the potential for digoxin induced ventricular arrhythmias in dogs. J. Pharmacol. Exp. Ther., 240, 548-553.
95) WARNER, N. J., LEAHE Y,E.B.Jr., HOUGEN, T. J., BIGGER, J. T. Jr, and SMITH, T. W. (1983): Tissue digoxin concentrations during the quinidine-digoxin interaction. Am. J. Cardiol., 51, 1717-1721.
96) PEDERSOLI, W.M., RAVIS, W.R. and NACHREINER, R.F. (1983): Serum digoxin concentrations in healthy dogs before, during, and after concomitant treatment with furosemide, hydrochlorthiazide, and phenytoin. J. Am. Anim. Hosp. Assoc., 19, 1031-1036.
97) PEDERSOLI, W. M., GANJAM, V. K. and NACHREINER R. F. (1980) : Serum digoxin concentrations in dogs before, during, and after concomitant treatment with phenobarbital. Am. J. Vet. Res., 41, 1639-1642.
98) PLUNKETT, L. M., GOKHALE, R. D., VALLNER, J. J. and TACKETT, R. L. (1985): Prazosin alters free and total plasma digoxin levels in dogs. Am. Heart J., 109, 847-851.
100) STEINESS, E.(1978): Digoxin toxicity compared with myocardial digoxin and potassium concentration. Br. J. Pharmacol., 63, 233-237.
101) PEDERSOLI, W. M. and NACHREINER, R. F. (1980): Serum digoxin concentrations in dogs before and during concomitant administration of furosemide. J. Vet. Pharmacol. Therap., 3, 1-7.
102) GIBSON, T. P. and QUINTANILLA, A. P. (1980): Effect of volume expansion and furosemide diuresis on the renal clearance of digoxin. J. Pharmacol. Exp. Ther., 219, 54-59.
103) WILKERSON, R. D.(1981): Acute effects of intravenous furosemide administration on serum digoxin concentration. Am. Heart J., 102, 63-65.
104) MUSGRAVE, G. E., BORN, C. K., DAVIDSON, C. P. and HAMRICK, M. E.(1977): Interaction of spircnolactcne and digoxin in dogs. J. Pharmacol. Exp. Ther., 202, 696-701.
105) Loo, J. C. K., ROWE, M. and MCGIVERAY, I. J. (1975): Effect of antacid on absorption of digoxin in dogs. J. Pharm. Sci., 64, 1727-1728.
106) ZAJTCHUK, R., CORBY, D. G., MILLER, J. G. and O'BARR, T .'P. (1975): Treatment of digoxin toxicity with activated charcoal. Am. J. Cardiol., 35, 178.
107) SCHULZ, P. and BLASCHKE, T. F. (1984): Pharmacokinetic interaction of single doses of quinine and digoxin in dogs. Pharmacology, 28, 343-346.
108) PEDERSOLI, W. M.(1980) : Serum digoxin concentrations in dogs before and after concomitant treatment with chloramphenicol. J. Am. Anim. Hosp. Assoc, 16, 839-844.
109) VARGO, T., LEWIS, R., PURDINE, J. and SCHWARTZ, A. (1975): Comparison between puppies and adult dogs following infution of digoxin. Pediatr. Res., 8, 355.
110) SINGH, S., GADGIL, S. and MIRKIN, B. L. (1978): Age dependent factors influencing digoxin pharmacokinetics in the postnatal puppy. Res. Commun. Chem. Pathol. Pharmacol., 21, 87-101.
112) DOHERTY, J. E. and YERKINS, W. H.(1966): Digoxin metabolism in hypo-and hyper-thyroidism: Studies with tritiated digoxin in thyroid disease. Ann. Inter. Med., 64, 489-507.
113) HARRON, D. W. G., SWANTON, J. G. COLLIER, P. S. and CULLEN, A. B.(1978): Digoxin plasma and myocardial level correlaticn in hypoxic dogs. J. Pharm. Pharmacol., 30(suppl.): 58 p.

責任著者(Corresponding author)

訂正情報

J-STAGEへの登録はこちら（無料）